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Introduction
Postnatal growth and regeneration of skeletal muscle mainly 
depend on adult muscle stem cells, named satellite cells. Sat-
ellite cells are characterized by the expression of the paired-
box  transcription  factor  Pax7  (Buckingham,  2007;  Kuang   
et al., 2008). Mouse genetics and cell culture studies reveal that 
Pax7 is required for satellite cell survival, proliferation, and to 
prevent precocious differentiation of myogenic progenitor cells 
(Oustanina et al., 2004; Kuang et al., 2006; Relaix et al., 2006; 
Zammit et al., 2006). Gene targeting studies show that satellite 
cells that lack Pax7 and its close homologue, Pax3, die or differ-
entiate into cartilage and other cell types (Relaix et al., 2005). 
However, Pax3 and Pax7 have been shown to function upstream 
of MyoD to activate skeletal muscle gene expression and to ini-
tiate the myogenesis program (Relaix et al., 2006). However, 
sustained expression of Pax7 in satellite cells delays the onset of 
myogenesis, and elevated expression of Pax7 in primary myoblasts 
inhibits the expression of MyoD, preventing myogenin induc-
tion and muscle terminal differentiation (Olguin and Olwin, 
2004; McFarlane et al., 2008). These studies suggest that Pax7 
plays a dual role in satellite cell fate maintenance and myogenic 
progenitor cell differentiation. These observations further imply 
that precise regulation of Pax7 is crucial for satellite cell transi-
tion from proliferation/self-renewal to differentiation.
MicroRNAs (miRNAs) are a class of 22 nucleotide non-
coding RNAs that regulate gene expression at the posttranscrip-
tional level. The involvement of miRNAs in muscle biology has 
recently been reported. miRNAs regulate the expression of tran-
scription factors and signaling mediators important for cardiac 
and  skeletal  muscle  development  and  function  (Callis  and 
Wang, 2008; van Rooij et al., 2008). Aberrant miRNA expres-
sion has been observed in muscle diseases, including cardiac 
and skeletal muscle hypertrophy, heart failure, and muscular 
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sponsible for postnatal skeletal muscle growth and 
regeneration. Paired-box transcription factor Pax7 
plays a central role in satellite cell survival, self-renewal, 
and proliferation. However, how Pax7 is regulated during 
the transition from proliferating satellite cells to differenti-
ating myogenic progenitor cells is largely unknown. In this 
study, we find that miR-1 and miR-206 are sharply up-
regulated during satellite cell differentiation and down-
regulated after muscle injury. We show that miR-1 and 
miR-206 facilitate satellite cell differentiation by restricting 
their  proliferative  potential.  We  identify  Pax7  as  one   
of the direct regulatory targets of miR-1 and miR-206.   
Inhibition of miR-1 and miR-206 substantially enhances 
satellite cell proliferation and increases Pax7 protein   
level in vivo. Conversely, sustained Pax7 expression as   
a result of the loss of miR-1 and miR-206 repression   
elements at its 3 untranslated region significantly inhibits 
myoblast differentiation. Therefore, our experiments sug-
gest that microRNAs participate in a regulatory circuit 
that allows rapid gene program transitions from prolifera-
tion to differentiation.
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adult mice. We carefully tested and compared two protocols for 
satellite cell isolation according to previous studies (see Materi-
als and methods; Rosenblatt et al., 1995; Conboy and Rando, 
2002; Shefer and Yablonka-Reuveni, 2005; Shinin et al., 2006). 
In our experiments, the protocol using extensor digitorum longus 
(EDL)  muscle–derived  myofibers  yielded  the  purest  single 
myofiber and satellite cell preparations. Satellite cell prepara-
tions were consistently >90% pure, as indicated by the expres-
sion of Pax7 and 7-integrin and the absence of myogenin or 
myosin heavy chain (MyHC) expression (Fig. S1). Therefore, 
in this study, we adopted the satellite cell isolation protocol 
from single myofibers of EDL muscle. Isolated satellite cells 
were maintained on collagen-coated plates, and they continued 
to proliferate without differentiation when cultured in the pres-
ence of basic FGF (bFGF). However, shortly after removal of 
bFGF and cultured in low-serum medium (differentiation con-
dition), satellite cells quickly exited the cell cycle and initiated 
myogenic differentiation, a process that faithfully mimics the 
in vivo myogenesis process (Clegg et al., 1987; Templeton and 
Hauschka, 1992; Sabourin et al., 1999). The differentiation ca-
pacity of isolated satellite cells was confirmed by the expression 
of MyHC, a skeletal muscle terminal differentiation marker, 
upon differentiation induction (Fig. 1 A).
To assess the role of miRNAs in satellite cells, we isolated 
and cultured satellite cells from Dicer
flox/flox mice, in which   
exons 22 and 23 of the Dicer gene had been flanked by loxP   
sequences (Murchison et al., 2005; Chen et al., 2008). Dicer   
encodes  an  RNase  III  endonuclease  responsible  for  miRNA 
maturation; therefore, deletion of Dicer leads to depletion of all 
mature and functional miRNAs (Bernstein et al., 2001; Grishok 
et al., 2001). We infected the Dicer
flox/flox satellite cells with   
adenoviruses that expressed either the Cre recombinase (Ad-Cre) 
or the controls LacZ- (Ad-LacZ) or GFP- (Ad-GFP; Fig. 1 B). 
48 h after Ad-Cre infection, Dicer was deleted, and the expres-
sion of miRNAs was significantly decreased, as demonstrated 
by the decreased expression of miR-1, one of the most abundant 
miRNAs in skeletal muscle myoblasts and myotubes (Fig. 1, 
C and D). To assess the differentiation potential of the Dicer-
null satellite cells, we switched the Ad-Cre–infected Dicer
flox/flox 
satellite cells to differentiation medium (DM; Sabourin et al., 
1999). Interestingly, we observed a significant loss of cell via-
bility in Dicer-null satellite cells upon differentiation induction, 
as indicated by the increase of TUNEL-positive cells (Fig. S2, 
A and B). These observations are consistent with a previous 
study demonstrating that Dicer and miRNAs are required for 
stem cell survival (Bernstein et al., 2003).
We next investigated the effects of the Dicer mutation 
on satellite cell differentiation potential. We examined the 
expression  of  Pax7,  myogenin,  and  MyHC  in Ad-Cre  or   
Ad-LacZ–transduced satellite cells under growth or differentiation 
conditions.  Under  the  growth  condition,  in  which  both  the 
Dicer-null and wild-type satellite cells were maintained at an 
undifferentiated state, we observed essentially no difference in 
Pax7 expression level (unpublished data). 12 h after being 
switched to the DM, satellite cells started to differentiate. We 
detected similar myogenin expression in both Dicer-null and 
wild-type satellite cells (unpublished data). These observations 
dystrophy (Eisenberg et al., 2007; Tatsuguchi et al., 2007; Thum 
et al., 2007). We have previously shown that the expression of 
muscle-specific miR-1 and miR-133 is induced during skeletal 
muscle differentiation. We further demonstrated that miR-1   
and miR-133 play central regulatory roles in myoblast prolifera-
tion  and  differentiation  (Chen  et  al.,  2006).  Interestingly,   
miR-1 and miR-133 are also important regulators of cardio-
myocyte  differentiation  and  heart  development  (Zhao  et  al., 
2007; Ivey et al., 2008).
As stem cells differentiate, they turn on lineage-specific 
genes while down-regulating stem cell maintenance genes in 
response to appropriate cues (Jaenisch and Young, 2008; Rossant, 
2008). Although these maintenance genes are regulated mainly 
at  the  transcriptional  level,  remaining  transcripts  that  were 
highly expressed in the previous stage need to be effectively si-
lenced for optimal transition from one gene program to another. 
In this sense, miRNAs are well suited for clearing these residual 
messages. Genetic studies on the components of the miRNA bio-
genesis pathway indicate that Dicer and miRNAs are essential 
for embryonic stem cell survival and differentiation (Murchison   
et al., 2005; Wang et al., 2007). It was recently reported that a 
skin miRNA (miR-203) promotes the differentiation of skin 
progenitor cells by restricting cell proliferation and inducing 
cell cycle exit. miR-203 achieved this function by repressing 
p63, a key factor for skin stem cell fate maintenance (Yang   
et al., 1999; Senoo et al., 2007; Yi et al., 2008). Interestingly, 
muscle-specific miR-1 and miR-133 appear to play a role in 
cardiac differentiation from embryonic stem cells (Ivey et al., 
2008). Together, these studies indicate that miRNAs could be 
previously unrecognized regulators of muscle progenitor cell 
proliferation, fate specification, and differentiation.
In this paper, we study the function of miRNAs in skeletal 
muscle satellite cells and their derived myogenic progenitor 
cells. We find that miR-1 and miR-206 are highly induced dur-
ing satellite cell and primary myoblast differentiation. We show 
that miR-1 and miR-206 promote satellite cell differentiation 
and restrict their proliferative potential. We further identify Pax7 
as one of the direct regulatory targets of miR-1 and miR-206.   
In vivo knockdown of endogenous miR-1 and miR-206 in   
neonatal mouse skeletal muscle substantially enhances satellite 
cell proliferation and increases Pax7 protein level. In contrast, 
loss of miR-1 and miR-206 repression leads to sustained Pax7 
expression, which results in inhibition of myogenic progenitor 
cell differentiation. Together, our experiments uncover a key 
role of miRNAs in skeletal muscle satellite cells and myogenic 
progenitor cells in which miR-1 and miR-206 participate in a 
regulatory circuit that facilitates gene program transition from 
proliferation to differentiation.
Results
miRNAs are required for proper 
differentiation of satellite cells
To study the potential involvement of miRNAs in muscle stem 
cell differentiation, we first established a satellite cell in vitro 
differentiation  system.  Mouse  skeletal  muscle  satellite  cells 
were isolated from single myofibers of hind leg muscle of young 869 miRNAs in skeletal muscle satellite cells • Chen et al.
formation (Fig. 1, E and F). These data suggest that Dicer is es-
sential for both survival and terminal differentiation of skeletal 
muscle satellite cells.
miRNA expression during satellite cell 
differentiation and skeletal  
muscle regeneration
To define the signature of miRNA expression in satellite cells 
and myogenic progenitor cells and to identify miRNAs that are 
responsive to satellite cell differentiation, we performed miRNA 
microarray analyses on satellite cells, which were grown in 
suggest that miRNAs are not required for the initiation of satel-
lite cell differentiation. 24 h after switching to DM, control 
wild-type satellite cells further differentiated into myocytes, as 
indicated by the expression of MyHC proteins. However, very 
little MyHC expression was detected in Dicer-null cells (Fig. 1 E).   
3 d after differentiation induction, robust myogenic differen-
tiation was observed in control satellite cells, as demonstrated 
by multinucleated myotube formation and MyHC expression. 
However, Dicer-null satellite cells were unable to complete myo-
genic differentiation, as indicated by a much-reduced MyHC 
expression (Fig. 1 E) and absence of multinucleated myotube 
Figure 1.  miRNAs are required for skeletal muscle satellite cell differentiation in vitro. (A) Isolation and differentiation induction of satellite cells. Satellite 
cells under growth (0 h bFGF) or differentiation condition (48 h bFGF) were fixed and stained with antibodies against Pax7 or MyHC. DAPI-stained nuclei. 
Bars, 40 µm. (B) Scheme for the generation of Dicer-null satellite cells. LoxP sites (triangles) allow the deletion of Dicer after the infection of an adenoviral 
vector expressing Cre recombinase (Ad-Cre). Adenovirus-expressing GFP (Ad-GFP) or LacZ (Ad-LacZ) served as the control. WT, wild type. (C) RT-PCR analy-
ses of Dicer expression using RNAs isolated from Ad-Cre or Ad-LacZ–infected Dicer
flox/flox satellite cells at 48 h after infection and differentiation induction 
in DM. GAPDH was used as a loading control. (D) Northern blot analyses of miR-1 expression using the same set of RNAs as C. tRNAs were used as a 
loading control. (E) Satellite cells infected with Ad-LacZ or Ad-Cre were switched into DM for 1 (DM-1d) or 3 d (DM-3d), and myogenic differentiation was 
detected by immunostaining for MyHC. DAPI-stained nuclei. Bars, 20 µm. (F) Quantification of fusion event of myoblasts infected with Ad-LacZ or Ad-Cre at 
3 d in DM. The fusion index is calculated as the percentage of nuclei in fused myotubes out of the total nuclei for each microscopic field. Myotubes with two 
or more nuclei were defined as fused myotubes. nt, nucleotide. Error bars indicate SEM of 10 microscopic fields from three independent experiments.JCB • VOLUME 190 • NUMBER 5 • 2010   870
Consistent with a previous study (Yan et al., 2003), molecular 
marker analyses confirmed that 3 d after cardiotoxin injection cor-
responds to a stage of active satellite cell proliferation (Fig. 2 B). 
miRNA microarray data revealed that a subset of miRNAs, in-
cluding miR-1, miR-206, miR-133a, and miR-133b, were highly 
induced  during  satellite  cell  differentiation.  Intriguingly,  the   
expression of these miRNAs was markedly down-regulated in 
injured skeletal muscle where active muscle regeneration was 
growth medium (GM) and satellite cells that had been switched 
to DM for 1 d to induce differentiation (Fig. 2 A). We also used 
RNA from normal adult mouse skeletal muscle as well as from 
injured muscle 3 d after cardiotoxin injection to identify the 
miRNA expression signature during muscle regeneration in vivo. 
It has been well established that injury stimulates satellite cells 
to reenter the cell cycle and undergo extensive proliferation and 
differentiation (Morgan and Partridge, 2003; Yan et al., 2003). 
Figure 2.  miRNA expression pattern during satellite cell differentiation and adult skeletal muscle regeneration. (A) Microarray analyses of miRNA expres-
sion in differentiating satellite cells or regenerating skeletal muscle. Bar graph indicates the fold change in miRNA expression during satellite cell differen-
tiation and muscle regeneration compared with their respective controls. Group I represents miRNAs induced in differentiating satellite cells and repressed 
in regenerating muscle. Group II miRNAs are moderately induced in both differentiating satellite cells and regenerating muscle. miRNAs in group III   
are repressed in differentiating satellite cells and induced in regenerating muscle. Data represent two independent experiments in triplicate. P < 0.05.   
(B) RT-PCR analyses of RNAs isolated from noninjured or injured skeletal muscle for the indicated genes. GAPDH served as a loading control. (C) Alignment of 
mouse miR-1 and miR-206 sequences. (D) Northern blot analyses of miR-1 and miR-206 expression using RNAs isolated from satellite cells at different time 
points of differentiation induction. tRNAs were used as a loading control. (E) Immunofluorescence of satellite cells expressing a sensor construct containing 
the miR-1 complementary site (miR-1 sensor) or the mutated miR-1 complementary site (miR-1 sensor M) in GM or DM for 72 h. Note that the expression of 
miR-1 was inversely correlated with dsRed. miR-1 sensor, but not the mutant miR-1 sensor, was completely silenced in the differentiation condition in which 
miR-1 was highly expressed. Satellite cell identity and their differentiation status were confirmed by the expression of Pax7 and MyHC, respectively. DAPI-
counterstained nuclei. nt, nucleotide. Bar, 40 µm.871 miRNAs in skeletal muscle satellite cells • Chen et al.
cell colony formation assays (Montarras et al., 2005; Shinin   
et al., 2006). We applied a retroviral expression system modi-
fied from previous studies (Miller and Rosman, 1989; Grez et al.,   
1990), in which genomic sequences encoding miR-1 and miR-206   
were cloned upstream of a GFP cassette and were under the con-
trol of the cytomegalovirus promoter, which directs the expres-
sion of miR-1, miR-206, and GFP simultaneously (Fig. S2 E).   
We also validated the expression and activity of these miRNAs 
using both RNA Northern blot analyses and miR-1 sensor (Fig. S2 
and not depicted). Indeed, overexpression of miR-1 and miR-206 
significantly inhibits colony formation by satellite cells. Approxi-
mately 18 h after the retroviral infection, a similar number of 
colonies and a similar number of cells within individual colo-
nies were observed in the control and miR-1– and miR-206– 
infected satellite cells. At this stage, the majority of GFP-
positive colonies exhibited single- or two-cell pattern when plated 
at a low density (Fig. 3, D and E). However, 72 h after the retro-
viral infection, significantly fewer colonies were formed in 
miR-1– and miR-206–infected satellite cells compared with the 
control (Fig. 3, C–E). In addition, we found that 50% of colo-
nies contained >20 cells in the control satellite cells. In contrast, 
the number of colonies that contained >20 cells were much 
less in miR-1– and miR-206–infected satellite cells (Fig. 3 E). 
These results indicate that miR-1 and miR-206 restrict satellite 
cell proliferation and colony formation.
To study the effect of miR-1 and miR-206 on satellite cell 
differentiation, we performed immunofluorescent staining using 
an antibody against MyHC at different time points after the ini-
tiation of satellite cell differentiation induction. Indeed, miR-1 
and miR-206 accelerated satellite cell differentiation (Fig. 3 F). 
Quantitative analyses demonstrated that these changes are sta-
tistically significant (Fig. 3 G). Together, these data suggest that 
miR-1 and miR-206 restrict satellite cell proliferative potential 
and positively regulate satellite cell differentiation.
miR-1 and miR-206 restrict satellite cell 
proliferation in vivo
To investigate whether miR-1 and miR-206 also restrict the   
proliferative  potential  of  satellite  cells  in  vivo,  we  knocked 
down both miR-1 and miR-206 in the skeletal muscle of neo-
natal mice using miRNA antagomirs (Krutzfeldt et al., 2005; Yi   
et al., 2008). Administration of antagomir-1 and -206, but not 
PBS or mut–antagomir-1 and -206 (in which four mismatch 
mutations were introduced into each miRNA sequence), re-
sulted in a profound decrease in the endogenous expression 
level of miR-1 and miR-206 in skeletal muscle (Fig. 4 A). 
Both intraperitoneal (IP) injection and intramuscular injection 
of antagomir-1 and -206 markedly abolished endogenous miR-1 
and miR-206 in skeletal muscle (Fig. 4 and Fig. S3 A). The   
expression  of  miR-1  was  also  dramatically  abolished  in  the 
heart after IP injection (but not intramuscular injection) of 
antagomir-1 (unpublished data). Most importantly, the expression 
level of miR-133, which is clustered with miR-1 in the mouse 
genome and is normally cotranscribed with miR-1, was un-
affected by antagomir-1 and -206 under the same conditions   
(Fig. 4 A and Fig. S3), indicating that the action of antagomirs 
is highly specific.
occurring (Fig. 2 A, group I). Conversely, another set of miRNAs 
were highly induced in regenerating skeletal muscle, and their 
expression decreased in differentiating satellite cells. These in-
cluded miR-21 and others (Fig. 2 A, group III). In addition, we 
found that the expression of some miRNAs was moderately in-
creased in both differentiating satellite cells and regenerating 
skeletal muscle (Fig. 2 A, group II). These observations suggest 
that miRNAs are likely involved in the process of satellite cell 
proliferation, differentiation, and skeletal muscle regeneration.
Based on their high expression levels and dynamic change 
during satellite cell differentiation and muscle regeneration, we 
decided to focus on miR-1 and miR-206. Both miR-1 and miR-206 
belong to the miRNA family of miR-1, and they share a high 
homology in their sequences (Griffiths-Jones, 2004). Both miR-1 
and miR-206 contain identical “seed” sequences (bases 2–8 of 
the 5 end of the miRNA), suggesting that they likely regulate 
the same or very similar target genes (Fig. 2 C). The induction 
of miR-1 and miR-206 expression during satellite cell differen-
tiation was further confirmed by miRNA Northern blot analyses 
(Fig. 2 D). To precisely monitor the expression and action of 
these miRNAs at the single cell level in satellite cells, we used an 
miR-1 sensor, in which the complementary sequence for miR-1 
was cloned downstream of a dsRed coding sequence (Chen et al., 
2006). As a control sensor, the miR-1–binding sequence was   
mutated (miR-1 sensor M). When maintained in GM, similar 
dsRed expression levels were detected in both miR-1 sensor– 
expressed cells (miR-1 sensor) and control cells (miR-1 sensor M),   
indicating that miR-1 actually was nearly undetectable in un-
differentiated satellite cells (Fig. 2 E, top). However, when 
satellite cells were switched into DM to induce to differentia-
tion, the expression of dsRed was extinguished in miR-1 sensor 
cells, whereas control cells still exhibited strong dsRed (Fig. 2 E, 
bottom). These data further demonstrate that miR-1 actually is 
highly induced during satellite cell differentiation.
miR-1 and miR-206 restrict satellite cell  
proliferative potential and promote  
their differentiation
The sharp induction of miR-1 and miR-206 expression during 
the transition of satellite cells from proliferation to differentia-
tion, as well as their decreased expression in regenerating skele-
tal muscle, prompted us to investigate the role of these miRNAs in 
satellite cells and satellite cell–derived myogenic progenitor cells. 
We hypothesized that miR-1 and miR-206 repress the satellite cell 
proliferation program, thus facilitating myogenic differentiation. 
To test this hypothesis, we prematurely overexpressed miR-1, 
miR-206, or both in isolated satellite cells using adenoviruses. 
We validated the expression of miR-1, miR-206, or both using 
Northern blot analyses (Fig. S2 and not depicted). BrdU incor-
poration experiments were performed to assess the proliferation 
of satellite cells. miR-1 and miR-206 strongly inhibited satellite 
cell proliferation, as indicated by significantly less BrdU incor-
poration in miRNA-overexpressing satellite cells in comparison 
with control cells (n = 3 independent isolation and infection; 
Fig. 3, A and B).
To further characterize the inhibition of satellite cell prolif-
erative potential by miR-1 and miR-206, we performed satellite JCB • VOLUME 190 • NUMBER 5 • 2010   872
Pax7 is a direct regulatory target of  
miR-1 and miR-206 during satellite  
cell differentiation
Pax7, a paired-box transcription factor, has been well estab-
lished as a key regulator of satellite cell survival, self-renewal, 
and proliferation (Oustanina et al., 2004; Zammit et al., 2004; 
Relaix et al., 2006; McFarlane et al., 2008). The observation 
that overexpression of miR-1 and miR-206 in satellite cells dra-
matically inhibited colony formation and decreased the size of 
individual colonies prompted us to further examine the expres-
sion of Pax7 in miR-1– and miR-206–overexpressed satellite 
cells. Indeed, we observed an inverse correlation between the 
expression level of miR-1/miR-206 and Pax7 protein in satellite 
cell colonies (Fig. 5 A and Fig. S4), suggesting that miR-1 and 
miR-206  may  participate  in  the  repression  of  Pax7  protein 
expression. Parallel up-regulation of miR-1 and miR-206 and 
down-regulation of Pax7 during satellite cell differentiation led 
us to hypothesize that miR-1 and miR-206 directly inhibit Pax7 
gene expression.
To test this hypothesis, we searched for miR-1 and miR-206 
regulatory targets. Indeed, two putative miR-1– and miR-206–
binding sites were identified in the 3 untranslated region (UTR; 
of  Pax7  mRNA;  Fig.  S5).  Next,  we  performed  luciferase   
reporter assays using a partial sequence of the Pax7 3-UTR   
We examined the effects of miR-1 and miR-206 knock-
down on mouse skeletal muscle development and satellite cell 
proliferation. We first performed BrdU incorporation experi-
ments to label proliferating cells. Quantitative analyses revealed 
a significant increase in BrdU-positive cells in antagomir-1–   
and -206–treated skeletal muscle compared with control mut–
antagomir-1– and -206–treated samples (Fig. 4, B and C),   
indicating  that  the  knockdown  of  endogenous  miR-1  and   
miR-206 indeed enhanced muscle cell proliferation. Consistent 
with the aforementioned observation, we found substantially 
more phospho–histone H3-positive cells in antagomir-1– and 
-206–treated muscle than in control muscle (Fig. 4, D and E). 
To further confirm the satellite cell identity of these prolifer-
ating cells in skeletal muscle, we examined the expression of 
Pax7,  a  well-defined  marker  for  satellite  cells,  and  found  a 
significant increase in Pax7-positive cells in antagomir-1– and 
-206–treated skeletal muscle (Fig. 4, F and G; and Fig. S3). 
Quantitative analyses indicate that 88% of BrdU-positive cells 
were also positive for Pax7 in antagomir-1– and -206–treated 
skeletal muscle (Fig. S3 D). These in vivo results, together with 
our previous findings in which miR-1 and miR-206 inhibit sat-
ellite cell colony formation and proliferation in vitro, further 
support the view that miR-1 and miR-206 are key regulators of 
satellite cell proliferation.
Figure 3.  miR-1 and miR-206 restrict the proliferative potential of satellite cells and enhance their differentiation. (A) Satellite cells were infected with 
either Ad–miR-1+206 or Ad-GFP (control) and pulsed with 10 µM BrdU for 1.5 h. 12 h later, cell proliferation was determined by immunostaining using 
antibody against BrdU (red). DAPI-counterstained nuclei. Bar, 40 µm. (B) Quantification of BrdU labeling experiments. The BrdU-positive cells percentage 
was calculated as the percentage of BrdU-positive cells out of total number of cells indicated by DAPI-positive staining for each microscopic field. P < 0.02. 
Error bars indicate SEM of 10 microscopic fields from three independent experiments. (C) Satellite cell colony formation assays. Satellite cells were infected 
with retroviral vectors expressing miR-1 and miR-206 (miR-1+206) or mutated miR-1 and miR-206 (control) and colony size determined. Note the small 
size of colony expressing miR-1 and miR-206 (miR-1+206) compared with controls 72 h after retroviral infection. Bar, 20 µm. (D and E) Quantification 
of satellite cell colony formation assay results. The colony numbers (D) and the distribution of different colony size (E) were measured 18 and 72 h after 
retroviral vector infection. For colony size measurement at 72 h, only colonies containing more than five cells were counted. Data represent the mean ± 
SD from two independent experiments. (E) Red arrows indicate colonies that contain >40 cells. (F) Satellite cells infected with retroviral vector expressing 
miR-1+206 or GFP (control) were switched to DM for 48 h, and myogenic differentiation was determined by immunostaining for MyHC. Green, infected 
cells; red, MyHC. DAPI (blue)-counterstained nuclei. Bar, 20 µm. (G) Quantification of satellite cell differentiation at different time points after miR-1+206 
overexpression. Data represent the mean ± SD from three independent experiments. *, P < 0.05.873 miRNAs in skeletal muscle satellite cells • Chen et al.
miR-1 and miR-206–mediated repression of 
Pax7 is essential for myogenic progenitor 
cell differentiation
Pax7 plays a central role in satellite cell self-renewal and the 
initiation  of  the  myogenic  program  (Oustanina  et  al.,  2004; 
Zammit et al., 2004; Relaix et al., 2006). Intriguingly, it has also 
been observed that sustained expression of Pax7 in myogenic 
progenitor cells significantly represses myogenic terminal dif-
ferentiation (Olguin and Olwin, 2004; McFarlane et al., 2008). 
We hypothesized that miR-1 and miR-206–mediated repression 
of Pax7 protein level through its 3-UTR might be essential for 
the transition of myogenic progenitor cells from proliferation to 
differentiation. To test this hypothesis, we built two Pax7 ex-
pression constructs in which the 3-UTR was either included or 
excluded (referred to as Pax7-UTR and Pax7, respectively); we 
also built another Pax7 expression construct in which both the 
miR-1 and miR-206 targeting sites in its 3-UTR were mutated 
(referred to as Pax7-UTR–M; Fig. 6 A). We examined the effects 
of these Pax7 expression constructs on Pax7 protein expression 
and myoblast differentiation. To perform these experiments, we 
that contained both miR-1– and miR-206–binding sites (Fig. S5). 
Not surprisingly, miR-1, miR-206, or both strongly repressed 
Pax7 3-UTR luciferase activity (Fig. 5 B). Introduction of   
mutations into these two miRNA-binding sites completely 
abolished miR-1 and miR-206–mediated repression, demon-
strating the specificity of repression (Fig. 5 B). Furthermore, 
we  tested  whether  miR-1  and  miR-206  could  reduce  the   
endogenous  Pax7  protein  level  in  isolated  satellite  cells. 
Western blot analyses clearly demonstrate that miR-1 and 
miR-206  overexpression  reduced  Pax7  protein  expression 
(Fig. 5 C). Interestingly, although we observed a significant 
repression of Pax7 protein by miR-1 and miR-206, the ex-
pression level of Pax7 mRNA only decreased slightly (Fig. 5 C), 
indicating that a posttranscriptional regulation of Pax7 ex-
pression is likely involved. Finally, we found that the Pax7 
protein level was down-regulated during satellite cell dif-
ferentiation (Fig. 5 D), which is consistent with previous   
observations (Olguin et al., 2007). Together, these results 
demonstrate that miR-1 and miR-206 directly regulate Pax7 
protein expression posttranscriptionally.
Figure 4.  Knockdown of miR-1 and miR-206 increases the proliferation of satellite cells in vivo. (A) Northern blot analyses of total RNAs isolated from 
skeletal muscle 24 h after the last injection of RNA antagomirs against miR-1 and miR-206 (antagomir-1+206). Muscle injected with PBS or mutated miR-1 
and miR-206 antagomirs (mut–antagomir-1+206) were used as controls. tRNAs were used as a loading control. nt, nucleotide. (B) Confocal microscopic 
images of skeletal muscle 4 h after BrdU labeling from postnatal mice treated with antagomir-1+206 or mut–antagomir-1+206 (serves as a control). Cell 
proliferation was determined by anti-BrdU antibody (green), laminin (red)-marked cell surface, and DAPI (blue)-counterstained nuclei. Bar, 20 µm. (C) Quan-
titative measurement of BrdU-positive cells from experiments in B. The BrdU-positive cells percentage was calculated as the percentage of BrdU-positive cells 
out of the total number of cells indicated by DAPI-positive staining for each microscopic field. Error bars indicate SEM of 10 microscopic fields from three 
independent experiments. P < 0.01. (D) Confocal microscopic images of skeletal muscle from mice treated with antagomir-1+206 or mut–antagomir-1+206 
(controls). Anti-phospho–histone H3 antibody (red) visualized mitotic cells. DAPI (blue)-counterstained nuclei. Bar, 10 µm. (E) Quantitative measurement   
of phospho–histone H3 (p-H3)-positive cells from experiments in D. The phospho–histone H3-positive cells percentage was calculated as the percentage of 
phospho–histone H3-positive cells out of the total number of cells indicated by DAPI-positive staining for each microscopic field. Error bars indicate SEM 
of 10 microscopic fields from three independent experiments. P < 0.001. (F) Merged confocal microscopic images of skeletal muscle from antagomir-1+206 
or mut–antagomir-1+206–treated mice. Anti-Pax7 antibody–labeled satellite cells (green). Laminin (red)-outlined cell surface and DAPI (blue)-counterstained 
nuclei. Bar, 10 µm. (G) Quantitative measurement of Pax7-positive cells from experiments in F. The Pax7-positive cells percentage was calculated as the 
percentage of Pax7-positive cells out of the total number of cells indicated by DAPI-positive staining for each microscopic field. Error bars indicate SEM of 
10 microscopic fields from three independent experiments. P < 0.05.JCB • VOLUME 190 • NUMBER 5 • 2010   874
Figure 5.  Pax7 is a direct regulatory target of miR-1 and miR-206. (A) Confocal microscopic images of satellite cell colonies infected with retroviral vec-
tor expressing GFP–miR-1 and miR-206 or control (GFP only). Note that the expression of Pax7 is inversely correlated with the expression of miR-1+206 
(arrows and arrowheads) but not in the control. DAPI-counterstained nuclei. Dotted areas indicate satellite cells with high expression levels of miR-1 and 
miR-206. Bars, 20 µm. (B) Repression of Pax7 3-UTR by miR-1 and miR-206. Luciferase reporters were linked with Pax7 3-UTRs containing either puta-
tive miR-1/miR-206–binding sites (Luc-Pax7-3-UTR) or mutated miR-1– and miR-206–binding sites (Luc-Pax7-3-UTR–M). miR-1, miR-206, or miR-1+206 
plasmids were cotransfected with luciferase-UTR constructs, and luciferase activity was determined. miR-208 (control) was used to serve as a control for the 
specificity of miRNA. Data represent the mean ± SD from three independent experiments. *, P < 0.05. (C) RT-PCR (top) and Western blot (bottom) analyses 
of Pax7 mRNA and protein expression in satellite cells infected with retroviral vectors expressing miR-1+206 or a control GFP. GAPDH and -tubulin served 
as controls for loading. nt, nucleotide. (D) Western blot analyses of Pax7 protein expression in satellite cells after being switched to the differentiation condi-
tion at the indicated time points. -Tubulin served as a loading control.875 miRNAs in skeletal muscle satellite cells • Chen et al.
Figure 6.  Functional significance of miR-1– and miR-206–mediated repression of Pax7 during myoblast differentiation. (A) Scheme of expression con-
structs including a control plasmid, Pax7 ORF only (Pax7), Pax7 with its 3-UTR containing two miR-1– and miR-206–binding sites (Pax7-UTR), or with the 
two miR-1– and miR-206–binding sites mutated (Pax7-UTR–M). (B) Western blot analyses of Pax7 protein expression in skeletal muscle C2C12 myoblasts   
stably transfected with control, Pax7, Pax7-UTR, or Pax7-UTR–M expression constructs under growth condition. -Tubulin served as a loading control.   
(C) Expression of Pax7 and other myogenic markers in skeletal muscle C2C12 myoblasts stably transfected with control, Pax7, Pax7-UTR, or Pax7-UTR–M 
expression constructs under a differentiation condition (36 h after switched to DM). (top) RT-PCR analyses using the indicated primers. GAPDH served as 
a loading control. (bottom) Western blot analyses using antibodies for Pax7, myogenin, and MyHC. -Tubulin served as a loading control. nt, nucleotide. 
(D) Immunofluorescence of skeletal muscle C2C12 myoblasts stably transfected with the indicated Pax7 expression constructs (or control). Cells were either 
maintained in GM or switched to DM for an additional 48 h. The cells were stained with antibodies against MyHC or anti-Flag antibody for Pax7 expres-
sion. DAPI-counterstained nuclei. Bar, 40 µm.JCB • VOLUME 190 • NUMBER 5 • 2010   876
switched to the C2C12 myoblast cell line, which we could 
stably transfect with the indicated Pax7 expression constructs.   
Under the growth condition, where miR-1 and miR-206 expres-
sion was barely detected in myoblasts, the expression levels of 
Pax7 mRNAs and proteins were similar for all three Pax7 con-
structs (Fig. 6 B). However, under the differentiation condition, 
in which miR-1 and miR-206 are rapidly induced, the Pax7 protein 
expression level is significantly lower in Pax7-UTR–transfected 
cells compared with Pax7- or Pax7-UTR–M-transfected cells 
(Fig. 6, C and D). Importantly, we did not detect a significant 
difference in Pax7 mRNA levels when individual Pax7 expres-
sion constructs were stably expressed in myoblasts (Fig. 6 C), 
indicating that miR-1 and miR-206 contributed to the inhibition 
of Pax7 protein expression posttranscriptionally via its 3-UTR. 
As  expected,  under  the  differentiation  condition,  stable  cell 
lines with Pax7 and Pax7-UTR–M expression constructs showed 
profound inhibition of myoblast differentiation compared with 
cells that stably express Pax7-UTR, as indicated by a significant 
decrease  in  the  expression  of  skeletal  muscle  differentiation 
marker genes, including myogenin, skeletal muscle -actin, and 
MyHC (Fig. 6, C and D). Furthermore, we performed immuno-
fluorescent staining to examine the effects of different forms of 
Pax7 expression constructs on myoblast differentiation. Consis-
tently, myoblasts stably transfected with Pax7 or Pax7-UTR–M 
expression constructs displayed much less MyHC expression. 
In contrast, myoblasts stably transfected with the Pax7-UTR 
expression construct had comparable expression of MyHC with 
the control (Fig. 6 D), indicating that miR-1– and miR-206– 
mediated repression of Pax7 expression facilitates cell differen-
tiation. Collectively, these data demonstrate that down-regulation 
of Pax7 by miR-1 and miR-206 is functionally significant for the 
progression of skeletal muscle progenitor cell differentiation.
Discussion
In this study, we reveal a critical role of miR-1 and miR-206 in 
the repression of the proliferation of skeletal muscle satellite 
cells and their derived myogenic progenitor cells. We found that 
miR-1 and miR-206 are sharply up-regulated during satellite 
cell differentiation while strikingly decreased during skeletal 
muscle regeneration. Furthermore, we showed that premature 
overexpression of miR-1 and miR-206 restricts the proliferative 
potential of satellite cells and accelerates their myogenic differ-
entiation.  Conversely,  satellite  cell  proliferation  is  increased 
when miR-1 and miR-206 are knocked down in skeletal muscle 
in vivo. Furthermore, we identified Pax7 as one of the regula-
tory targets of miR-1 and miR-206 during satellite cell prolifer-
ation and differentiation. We showed that down-regulation of 
Pax7 by these two miRNAs is crucial for proper muscle pro-
genitor  cell  differentiation.  Our  observation  that  miR-1  and 
miR-206 facilitate satellite cell differentiation by limiting Pax7 
expression implies that miRNAs may play a key role in acceler-
ating  the  transition  from  cell  proliferation  to  differentiation. 
Our conclusion is consistent with a recent study in which   
miR-203 was shown to promote skin progenitor cell differentiation 
by repressing the expression of P63, a key transcription factor 
for skin stem cell fate maintenance (Yi et al., 2008). It will be 
interesting to determine whether similar miRNA-mediated gene 
regulation mechanisms exist in other adult stem cells, such as 
adult neural stem cells and hematopoietic stem cells.
Recently, it was reported that the myogenic regulatory 
factors MyoD and myogenin inhibit the expression of Pax7 
in skeletal muscle primary myoblasts during differentiation   
(Olguin et al., 2007). However, the molecular mechanism under-
lying this observation was not well defined. Our experiments, 
in which miR-1 and miR-206 repress Pax7 protein expression 
in differentiating muscle progenitor cells, offer an explanation. 
Pax7 is expressed in undifferentiated satellite cells and is re-
quired for the initial activation of Myf5 and MyoD when satel-
lite  cells  are  induced  to  differentiate  and  become  myogenic 
progenitor cells. Activated MyoD in satellite cell–derived myo-
genic progenitor cells will then turn on miR-1 and miR-206 
(Rao et al., 2006; Rosenberg et al., 2006). As a result, miR-1 
and miR-206 will repress Pax7 posttranscriptionally. Given the 
essential dual roles of Pax7 in satellite cell self-renewal and 
myogenic terminal differentiation inhibition, we suggest that 
the repression of Pax7 protein levels in activated satellite cell–
derived myogenic progenitor cells by miR-1 and miR-206 could 
be one of the major mechanisms through which miRNAs regu-
late satellite cell transition between self-renewal and differenti-
ation (Fig. 7).
We and others previously demonstrated that miR-1 and 
miR-206 promote skeletal muscle terminal differentiation (Chen 
et al., 2006; Kim et al., 2006; Rosenberg et al., 2006; Williams 
et al., 2009). One of the miR-1 regulatory targets that mediates 
miRNA function in myoblasts is HDAC4, an inhibitor of muscle 
differentiation. HDAC4 was also shown repressed by miR-206 
(Lu et al., 2000; McKinsey et al., 2000; Chen et al., 2006;   
Williams et al., 2009). In this study, we further show that miR-1 
and miR-206 repress transcription factor Pax7, therefore con-
ferring robustness to the gene program transition from prolifer-
ation  to  differentiation  in  satellite  cells.  Interestingly,  both 
miR-1 and miR-206 were sharply down-regulated in injured 
skeletal muscle, presumably to allow active satellite cell prolif-
eration and regeneration. This study, together with our previous 
study (Chen et al., 2006), supports the view that miRNAs may 
regulate multiple mRNA targets that encode proteins with re-
lated functions (Leung and Sharp, 2007). A recent study showed 
that miR-27 represses the expression level of Pax3, another im-
portant transcription regulator for satellite cells and myogenic 
progenitor cells, thereby enhancing the myogenic differentia-
tion program (Crist et al., 2009). It will be important to identify 
and study additional miR-1 and miR-206 regulatory targets in 
skeletal muscle, which will be essential to further our under-
standing of the molecular mechanisms of miRNA function.   
Intriguingly, the expression of miR-133 was also found to   
be increased in differentiated satellite cells and decreased in   
injured skeletal muscle, similar to the expression patterns of   
miR-1 and miR-206. We and others have reported that miR-1 and 
miR-133 are cotranscribed in cardiac and skeletal muscle on a 
polycistronic primary transcript. Unlike miR-1, which strongly 
promotes myoblast differentiation, miR-133 inhibits myoblast 
differentiation and enhances proliferation (Chen et al., 2006). 
Similar observations were also reported in embryonic stem cells 877 miRNAs in skeletal muscle satellite cells • Chen et al.
10 µg /ml concentration. GFP-positive cells and single cell–derived colonies 
were counted at 18, 40, or 72 h after the infections.
C2C12  myoblasts  were  maintained  at  subconfluent  densities  in 
DME supplemented with 20% FBS (GM). Myogenic differentiation was in-
duced by changing subconfluent cells to DME containing 2% heat-inactivated 
horse serum (DM; Chen et al., 2006). To examine the effect of Pax7 ex-
pression on myoblast differentiation, C2C12 myoblasts were transfected 
with control, Pax7, Pax7-UTR, or Pax7-UTR–M expression constructs and 
cultured for 12 h under growth condition after transfection. They were then 
selected using puromycin at 10 µg/ml for 7 d. Stable cell lines were main-
tained on GM plus 5 µg /ml puromycin. The expression of Pax7 and myo-
genic markers was examined using RT-PCR and/or Western blot analyses. 
The stable cell lines harboring different Pax7 expression constructs were 
switched to DM for 36 h before immunostaining or Western blot analyses.
Generation of adenoviral vectors, retroviral vectors, and cell infection
Ad-Cre, Ad-LacZ, and Ad-GFP adenoviruses were provided by the Univer-
sity of North Carolina vector core. Ad–miR-1, Ad–miR-206, and Ad–miR-1/
miR-206 vectors were generated using standard molecular biology tech-
niques. High-titer viruses were prepared as described previously (He et al., 
1998) and purified using ViraBind Adenovirus Purification kit (Cell Biolabs, 
Inc.). For cell transfection, satellite cells were cultured for 2 d in GM in the 
presence of bFGF. They were infected with adenoviruses at 37°C at a mul-
tiplicity of infection of 20–80 for 12 h. Cells were maintained on GM for 
2–3 additional days before immunofluorescent staining. Alternatively, cells 
were induced to differentiate in DME medium with 2% horse serum for the 
duration of the time indicated in Figs. 1–7. Myogenesis was analyzed by 
immunostaining, RT-PCR, or Western blot analysis with indicated markers.
To generate retroviral miR-1, miR-206, and miR-1/miR-206 constructs, 
the murine stem cell virus vector (MaRX IVfPuro) was modified to carry 
splicing donor and splicing acceptor sequences where miRNA precursor 
sequences were inserted (provided by S. Hammond, University of North 
Carolina at Chapel Hill, Chapel Hill, NC; Fig. S2). The retroviral vectors 
were generated using standard molecular biology techniques according 
to  the  manufacturer’s  recommendation.  293  lupus  erythematosus  cells 
were transfected with 6 µg retroviral vectors, 3 µg envelope plasmids, and   
3 µg gag-pol plasmids (Fugene6; Roche). Viral supernatants from 293LE 
cells were filtered through a 0.2 µm syringe and subsequently used to 
infect satellite cells as described previously (Springer and Blau, 1997). 
In brief, growing satellite cells were immersed in viral supernatant in the 
presence of 20% FBS, 8 µg /ml polybrene, and 5.0 ng/ml bFGF, returned 
to the CO2 incubator for 15 min, and the dish was centrifuged at 32°C 
for 30 min at 1,100 g. After centrifugation, satellite cells were replaced 
with fresh GM containing 20% FBS and 5.0 ng/ml bFGF and cultured 
that were induced to differentiate into cardiomyocytes (Ivey   
et al., 2008). It will be important to determine whether miR-133 
affects satellite cell proliferation and differentiation processes, 
and if so, investigate the downstream regulatory targets that   
mediate such function. In addition, it will be interesting to ex-
plore whether similar miR-1 regulatory targets and molecular 
mechanisms exist in cardiomyocytes, where miR-1 is also 
highly expressed.
In  summary,  our  findings  demonstrate  that  miR-1  and 
miR-206 regulate the transition of skeletal muscle satellite cells 
from proliferation to differentiation. They do so, at least par-
tially, by limiting and refining the expression of important genes 
that are responsible for the maintenance of adult stem cells in an 
undifferentiated, self-renewing state. In this manner, miRNAs 
confer robustness to participate in a feed-forward genetic circuit 
that reinforces satellite cell commitment from self-renewal to 
myogenic differentiation. Therefore, miRNAs could be thera-
peutic tools and targets for human skeletal muscle disease.
Materials and methods
Mice, satellite cell isolations, and cell cultures
Mice carrying the Dicer floxed allele (Dicer
flox/flox) were described previ-
ously (Murchison et al., 2005; Chen et al., 2008). Single fibers and associ-
ated satellite cells were prepared from EDL muscles as described previously 
(Rosenblatt et al., 1995; Conboy and Rando, 2002; Shefer and Yablonka-
Reuveni, 2005; Shinin et al., 2006). Primary isolated satellite cells were 
plated on collagen-coated dishes (Roche) in Ham’s F-10 medium (Invitro-
gen) containing 20% FBS (Sigma-Aldrich), 1% penicillin/strep, and fed 
with 5.0 ng/ml bFGF (Invitrogen). The identity of satellite cells was determined 
by the expression of Pax7 proteins. Satellite cell differentiation was in-
duced culturing in F-10 with 2% horse serum lacking bFGF or FBS as de-
scribed previously (Frock et al., 2006).
For satellite cell colony formation assays, isolated satellite cells from 
single myofibers were plated on poly-d-lysine–coated dishes (Sigma-Aldrich) 
at 100 cells/cm
2 for overnight culture. Satellite cells were infected by 
retroviruses and cultured overnight before selection using puromycin at   
Figure  7.  Model  of  miR-1–  and  miR-206–
mediated repression of Pax7 for satellite cell 
differentiation.  Pax7  has  multiple  functions  in   
satellite cell fate determination. One such role 
is to specify satellite cells into myogenic fate 
while preventing their precocious differentia-
tion. Upon the initiation of myogenic differentia-
tion, satellite cell–derived myogenic progenitor 
cells will start to express myogenic transcrip-
tion factors, including MyoD, which, in turn, 
will  activate  the  expression  of  miR-1  and 
miR-206. miR-1 and miR-206 potently enhance 
the myogenic program by limiting and refining 
the expression of Pax7 in myogenic progenitor 
cells and myoblasts in addition to repressing 
HDAC4 (Chen et al., 2006), thereby confer-
ring  robustness  to  the  gene  program  switch 
from proliferation to differentiation.JCB • VOLUME 190 • NUMBER 5 • 2010   878
cholesterol linked through a hydroxyprolinol linkage. IP or intramuscular 
injection was performed on postnatal day 3 C57BL/6J mice. Antagomirs 
or controls were administrated twice at a dose of 80 mg/kg body weight 
in 0.01 ml/injection on every other day. Animals were sacrificed 24 h   
after the last injection for experimental analysis.
Online supplemental material
Fig. S1 shows the isolation and phenotypic characterization of skeletal 
muscle satellite cells. Fig. S2 shows that Dicer-depleted satellite cells exhibit 
higher rate of apoptosis in response to serum withdrawal. Fig. S2 also 
shows miR-1 sensor and retroviral vector expressing miR-1 and miR-206.   
Fig.  S3  shows  increased  Pax7-positive  satellite  cells  in  antagomirs-1–   
and -206–treated skeletal muscle. Fig. S4 shows that miR-1 and miR-206   
inhibit endogenous Pax7 protein expression. Fig. S5 shows the 3-UTR   
of Pax7 transcript containing two binding sites for miR-1 and miR-206.   
Online  supplemental  material  is  available  at  http://www.jcb.org/cgi/ 
content/full/jcb.200911036/DC1.
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overnight before selection using puromycin at 10 µg/ml concentration. 
Satellite  cells  were  maintained  on  selection  medium  for  an  additional   
4 d before analysis.
miRNA microarray, Northern blot, and RT-PCR analysis
miRNA microarray, Northern blot, and RT-PCR assays were performed as 
described previously (Chen et al., 2006). 5 µg and 10 µg total RNAs iso-
lated from skeletal muscle satellite cells were used for microarray and 
Northern blot assays, respectively.
Proliferation and differentiation assay, immunohistochemistry, and 
Western blot analysis
To measure cell proliferation, satellite cells infected with adenoviruses were 
maintained on GM for 48 h, pulsed with 10 µM BrdU (Sigma-Aldrich) for 
1.5 h, and fixed for immunostaining using anti-BrdU antibody at 1:1,000 
dilution (A21300; Invitrogen). To examine the expression level of endoge-
nous Pax7 in satellite cells after overexpression of miR-1 and miR-206,   
retroviral miR-1– and miR-206–infected satellite cells were cultured under 
10 µg /ml puromycin selection for 4 d before immunostaining or Western blot-
ting using Pax7 antibody at 1:100 dilution (Developmental Studies Hybrid-
oma Bank [DSHB], University of Iowa, Iowa City, IA). To examine myogenic 
differentiation of satellite cells after the removal of bFGF and FBS, retroviral 
miR-1– and miR-206–infected cells, induced to differentiate at different time 
points, were fixed for immunostaining using the MF20 antibody, which 
recognizes MyHC proteins (DSHB, University of Iowa). The following anti-
bodies and conditions were used for immunostaining and Western blot 
analyses for C2C12 myoblasts: MF20, 1:20 dilution in immunostaining 
and 1:100 dilution in Western blotting; myogenin (Santa Cruz Biotechnol-
ogy, Inc.), 1:200 dilution; Flag (F7425; Sigma-Aldrich), rabbit polyclonal 
at 1:400 dilution.
Histological  processing  and  immunochemical  staining  of  skeletal 
muscle tissues were performed as described previously (Yan et al., 2003). 
Skeletal muscle tissues were embedded in optimal cutting temperature com-
pound before 10 µm cyrosectioning (Chen et al., 2008). For costaining of   
Pax7 and BrdU, M.O.M. blocking kit (Vector Laboratories) and avidin/ 
biotin blocking kit (Vector Laboratories) were used to stain muscle sections. 
The primary antibodies used were Pax7 (DSHB, University of Iowa) and 
biotin-BrdU (Invitrogen). The secondary antibodies used were avidin-FITC 
and Alex Fluor 594 goat anti–mouse IgG (Invitrogen). All images were 
acquired by a camera (UFX-DX; Nikon) mounted on an inverted (TE2000; 
Nikon) or upright fluorescence microscope (Microphot-SA; Nikon). Digital 
fluorescent images were captured at room temperature with a Plan Fluor 
air 10× NA 0.30, Plan Fluor air 20× NA 0.45, or Plan Fluor air 40× NA 
0.60 objective lens using the least possible exposure to minimize bleach-
ing. Confocal microscopic images (Figs. 3–5 and Fig. S3) were captured 
using a confocal laser-scanning microscope (FV 500; Olympus) with a Plan 
Apochromat 63× NA 1.40 oil objective lens (Microscopy Service Labora-
tory,  University  of  North  Carolina).  The  images  were  processed  using 
SPOT (version 3.5.4 for MacOS; Diagnostic Instruments, Inc.) software 
and were scaled down and cropped in Photoshop (Adobe) to prepare the 
final figures.
TUNEL assay
Satellite cells carrying Dicer
flox/flox alleles were isolated using the same pro-
tocol as described for wild-type satellite cell isolation. Isolated Dicer
flox/flox 
satellite cells were infected with Ad-Cre or Ad-LacZ (as a control) for 12 h. 
Ad-LacZ– or Ad-Cre–infected Dicer
flox/flox satellite cells were cultured under 
growth condition for an additional 72 h and switched to differentiation 
condition for 5 h before TUNEL assay. TUNEL assays were performed   
using ApopTaq Fluorescein in situ Apoptosis Detection kit (Millipore) ac-
cording to the manufacturer’s instructions.
Antagomir synthesis and injection
Antagomir-1, mut–antagomir-1, antagomir-206, and mut–antagomir-206 
were designed and synthesized (Thermo Fisher Scientific) as described 
previously (Krutzfeldt et al., 2005). The antagomir-1 sequence was 5-*m 
A*mAmUmAmCmAmUmAmCmUmUmCmUmUmUmAmCmAmU*mU*mC
*mC*mAChl-3, and the mut–antagomir-1 sequence was 5-*mA*mAmU 
mcmCmAmUmgmCmUmcmCmUmUmUmAmCmAmg*mU*mC*mC*mAC
hl-3. The antagomir-206 sequence was 5-*mA*mCmCmAmCmAmCmA
mCmUmUmCmCmUmUmAmCmAmU*mU*mC*mC*mAChl-3,  and  the 
mut–antagomir-206 sequence was 5-*mA*mCmCmcmCmAmCmgmCmU
mcmCmCmUmUmAmCmAmg*mU*mC*mC*mAChl-3. Lowercase letters 
represent the mismatched sequence, “m” represents the 2’-O-methyl–modified 
nucleotide, “*” indicate a phosphorothioate linkage, and “Chl” indicates   879 miRNAs in skeletal muscle satellite cells • Chen et al.
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